Effect of mesenchymal stromal cells encapsulated within polyethylene glycol-collagen hydrogels formed in situ on alkali-burned corneas in an ex vivo organ culture model.
collagen
cornea
encapsulation
mesenchymal stromal cells
regeneration
wound healing
Journal
Cytotherapy
ISSN: 1477-2566
Titre abrégé: Cytotherapy
Pays: England
ID NLM: 100895309
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
06
10
2020
revised:
01
02
2021
accepted:
01
02
2021
pubmed:
24
3
2021
medline:
16
10
2021
entrez:
23
3
2021
Statut:
ppublish
Résumé
Corneal inflammation after alkali burns often results in vision loss due to corneal opacification and neovascularization. Mesenchymal stem cells (MSCs) and their secreted factors (secretome) have been studied for their anti-inflammatory and anti-angiogenic properties with encouraging results. However, topical instillation of MSCs or their secretome is often accompanied by issues related to delivery or rapid washout. Polyethylene glycol (PEG) and collagen are well-known biomaterials used extensively in scaffolds for tissue engineering. To effectively suppress alkaline burn-induced corneal injury, the authors proposed encapsulating MSCs within collagen gels cross-linked with multi-functional PEG-succinimidyl esters as a means to deliver the secretome of immobilized MSCs. Human MSCs were added to a neutralized collagen solution and mixed with a solution of four-arm PEG-N-hydroxysuccinimide. An ex vivo organ culture was conducted using rabbit corneas injured by alkali burn. MSCs were encapsulated within PEG-collagen hydrogels and injected onto the wounded cornea immediately following alkali burn and washing. Photographs of the ocular surface were taken over a period of 7 days after the alkali burn and processed for immunohistochemical evaluation. Samples were split into three groups: injury without treatment, MSCs alone, and MSCs encapsulated within PEG-collagen hydrogels. All corneas in ex vivo organ culture lost their transparency immediately after alkali burn, and only the groups treated with MSCs and MSCs encapsulated within PEG-collagen hydrogels recovered some transparency after 7 days. Immunohistochemical analysis revealed increased expression of vimentin in the anterior corneal stroma of the group without treatment indicative of fibrotic healing, whereas less stromal vimentin was detected in the group containing MSCs encapsulated within the PEG-collagen hydrogels. PEG-collagen hydrogels enable the encapsulation of viable MSCs capable of releasing secreted factors onto the ocular surface. Encapsulating MSCs within PEG-collagen hydrogels may be a promising method for delivering their therapeutic benefits in cases of ocular inflammatory diseases, such as alkali burn injuries.
Sections du résumé
BACKGROUND AIMS
Corneal inflammation after alkali burns often results in vision loss due to corneal opacification and neovascularization. Mesenchymal stem cells (MSCs) and their secreted factors (secretome) have been studied for their anti-inflammatory and anti-angiogenic properties with encouraging results. However, topical instillation of MSCs or their secretome is often accompanied by issues related to delivery or rapid washout. Polyethylene glycol (PEG) and collagen are well-known biomaterials used extensively in scaffolds for tissue engineering. To effectively suppress alkaline burn-induced corneal injury, the authors proposed encapsulating MSCs within collagen gels cross-linked with multi-functional PEG-succinimidyl esters as a means to deliver the secretome of immobilized MSCs.
METHODS
Human MSCs were added to a neutralized collagen solution and mixed with a solution of four-arm PEG-N-hydroxysuccinimide. An ex vivo organ culture was conducted using rabbit corneas injured by alkali burn. MSCs were encapsulated within PEG-collagen hydrogels and injected onto the wounded cornea immediately following alkali burn and washing. Photographs of the ocular surface were taken over a period of 7 days after the alkali burn and processed for immunohistochemical evaluation. Samples were split into three groups: injury without treatment, MSCs alone, and MSCs encapsulated within PEG-collagen hydrogels.
RESULTS
All corneas in ex vivo organ culture lost their transparency immediately after alkali burn, and only the groups treated with MSCs and MSCs encapsulated within PEG-collagen hydrogels recovered some transparency after 7 days. Immunohistochemical analysis revealed increased expression of vimentin in the anterior corneal stroma of the group without treatment indicative of fibrotic healing, whereas less stromal vimentin was detected in the group containing MSCs encapsulated within the PEG-collagen hydrogels.
CONCLUSIONS
PEG-collagen hydrogels enable the encapsulation of viable MSCs capable of releasing secreted factors onto the ocular surface. Encapsulating MSCs within PEG-collagen hydrogels may be a promising method for delivering their therapeutic benefits in cases of ocular inflammatory diseases, such as alkali burn injuries.
Identifiants
pubmed: 33752960
pii: S1465-3249(21)00034-7
doi: 10.1016/j.jcyt.2021.02.001
pmc: PMC10069134
mid: NIHMS1685625
pii:
doi:
Substances chimiques
Alkalies
0
Biocompatible Materials
0
Hydrogels
0
Polyethylene Glycols
3WJQ0SDW1A
Collagen
9007-34-5
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
500-509Subventions
Organisme : RRD VA
ID : I21 RX003179
Pays : United States
Organisme : NEI NIH HHS
ID : K08 EY028176
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY026877
Pays : United States
Informations de copyright
Published by Elsevier Inc.
Références
Eur J Pharm Biopharm. 2005 Jul;60(2):227-40
pubmed: 15939235
Stem Cells Transl Med. 2019 May;8(5):478-489
pubmed: 30644653
Cell Death Dis. 2016 Jan 21;7:e2062
pubmed: 26794657
J Cataract Refract Surg. 2017 Aug;43(8):1010-1014
pubmed: 28917398
Asian J Pharm Sci. 2019 Jan;14(1):1-15
pubmed: 32104434
Cytokine Growth Factor Rev. 2019 Apr;46:1-9
pubmed: 30954374
Surv Ophthalmol. 2018 Mar - Apr;63(2):214-235
pubmed: 28935121
Stem Cells. 2007 Apr;25(4):903-10
pubmed: 17218399
Macromol Biosci. 2007 Jan 5;7(1):23-39
pubmed: 17195277
Sci Rep. 2020 Oct 7;10(1):16671
pubmed: 33028837
Br J Ophthalmol. 1982 Nov;66(11):705-8
pubmed: 6896993
Trends Biotechnol. 2007 May;25(5):224-30
pubmed: 17379341
Biochimie. 2013 Dec;95(12):2229-34
pubmed: 23685070
Acta Biomater. 2019 Nov;99:247-257
pubmed: 31539656
Tissue Eng Regen Med. 2018 Jul 25;15(6):673-697
pubmed: 30603588
Acta Biochim Pol. 2015;62(3):329-37
pubmed: 26200199
Biomaterials. 2006 Oct;27(30):5268-76
pubmed: 16797067
Adv Healthc Mater. 2018 Oct;7(19):e1800560
pubmed: 30106514
Surv Ophthalmol. 1997 Jan-Feb;41(4):275-313
pubmed: 9104767
Cell Transplant. 2016;25(5):829-48
pubmed: 26423725
J Cell Physiol. 2019 Jun;234(6):8249-8258
pubmed: 30378105
Biomaterials. 2013 May;34(14):3571-80
pubmed: 23422594
Biomaterials. 2019 Dec;225:119516
pubmed: 31574405
Stem Cells. 2013 Jan;31(1):146-55
pubmed: 23034897
Exp Eye Res. 2009 Aug;89(2):133-9
pubmed: 19285070
Ann Biomed Eng. 2015 Mar;43(3):657-80
pubmed: 25537688
Biomaterials. 2017 May;125:38-53
pubmed: 28226245
Stem Cells. 2007 Oct;25(10):2648-59
pubmed: 17615264
Biochimie. 2018 Dec;155:16-25
pubmed: 29698670
Invest Ophthalmol Vis Sci. 2018 Oct 1;59(12):5194-5200
pubmed: 30372747
Acta Biomater. 2012 Jan;8(1):124-32
pubmed: 21911086
Stem Cells Int. 2018 Jun 14;2018:3057624
pubmed: 30013600
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5413-8
pubmed: 12686696
Arch Ophthalmol. 1980 Oct;98(10):1773-7
pubmed: 7425901
Stem Cells Int. 2016;2016:9176357
pubmed: 26649054
Nat Rev Nephrol. 2018 Aug;14(8):493-507
pubmed: 29895977
Mater Sci Eng C Mater Biol Appl. 2018 Apr 1;85:68-78
pubmed: 29407158
Adv Med Sci. 2016 Mar;61(1):101-12
pubmed: 26651127
Sci Rep. 2017 Jan 16;7:40582
pubmed: 28091556
Biomaterials. 2000 Nov;21(22):2215-31
pubmed: 11026628
Biomacromolecules. 2007 Sep;8(9):2883-9
pubmed: 17691843
Cornea. 2009 Jun;28(5):541-6
pubmed: 19421042
Stem Cells Transl Med. 2018 Dec;7(12):906-917
pubmed: 30260581
Wounds. 2017 Jan;29(1):20-27
pubmed: 28157686
Ophthalmol Ther. 2013 Dec;2(2):55-72
pubmed: 25135807
Stem Cell Res Ther. 2016 Mar 09;7:37
pubmed: 26960535
Cell Stem Cell. 2018 Jun 01;22(6):824-833
pubmed: 29859173
Chem Rev. 2001 Jul;101(7):1869-79
pubmed: 11710233
J Anat. 2015 Dec;227(6):717-31
pubmed: 25382217
Tissue Eng Part B Rev. 2008 Jun;14(2):149-65
pubmed: 18498217
Biomaterials. 2010 Sep;31(26):6675-84
pubmed: 20561680
J Burn Care Res. 2014 May-Jun;35(3):261-8
pubmed: 23877138
Cornea. 2019 Jan;38(1):8-12
pubmed: 30199398